These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2445645)

  • 1. Elevated HLA class I antigen expression on peripheral blood mononuclear cells of HBsAg carriers with coexistent human immunodeficiency virus infection.
    Paul RG; Roodman ST; Paul DA; Perrillo RP
    Hepatology; 1987; 7(6):1326-9. PubMed ID: 2445645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HLA antigens in blood donors, asymptomatic chronic carriers of the viral hepatitis type B surface antigen (HBsAg)].
    Morales VH; Barbetti A; Basualdo JA; Jmelnitzky A; Landoni N; Ponce de León H; Chopita N; de Torres RA
    Medicina (B Aires); 1983; 43(2):175-80. PubMed ID: 6664285
    [No Abstract]   [Full Text] [Related]  

  • 3. Increase of the prevalence of hepatitis B virus surface antigen related to immunodeficiency inherent in acquired immune deficiency syndrome (AIDS).
    Ouattara SA; Meite M; Aron Y; Akran V; Gody M; Manlan LK; de-The G
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):282-6. PubMed ID: 2154578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection.
    Wakita T; Kakumu S; Yoshioka K; Ishikawa T; Ito Y; Shinagawa T
    Digestion; 1992; 52(1):26-33. PubMed ID: 1426694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study.
    Rosina F; Saracco G; Rizzetto M
    N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication.
    Petit MA; Zoulim F; Capel F; Dubanchet S; Dauguet C; Trepo C
    Hepatology; 1990 May; 11(5):809-14. PubMed ID: 2347555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hepatitis B virus antigens on interferon-gamma production of peripheral blood mononuclear cells from hepatitis B virus carriers and healthy individuals.
    Katayama K; Hayashi N; Takehara T; Kawanishi Y; Kasahara A; Fusamoto H; Kamada T
    Scand J Gastroenterol; 1994 Sep; 29(9):849-53. PubMed ID: 7824867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histocompatibility-(HLA) antigens in patients with HBsAg positive and negative hepatitis and healthy carriers of HBsAg and anti-HBs. (author's transl)].
    Freudenberg J; Meyer zum Büschefelde KH; Arnold W; Berger J; Weiller H; Knolle J; Hopf U; Hütteroth T
    Klin Wochenschr; 1976 Jun; 54(12):579-83. PubMed ID: 940293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers.
    Arico S; Aragona M; Rizzetto M; Caredda F; Zanetti A; Marinucci G; Diana S; Farci P; Arnone M; Caporaso N
    Lancet; 1985 Aug; 2(8451):356-8. PubMed ID: 2862515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of delta infection in a group of haemodialysis carriers of HBsAg.
    Marinucci G; Valeri L; Di Giacomo C; Morganti D
    Prog Clin Biol Res; 1983; 143():151-4. PubMed ID: 6669567
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type B hepatitis.
    Chu CM; Shyu WC; Kuo RW; Liaw YF
    Hepatology; 1988; 8(3):712-7. PubMed ID: 3286466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen (HBSAg) in peritoneal fluid of HBSAg carriers undergoing peritoneal dialysis.
    Salo RJ; Salo AA; Fahlberg WJ; Ellzey JT
    J Med Virol; 1980; 6(1):29-35. PubMed ID: 7229625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Presence of HBsAg in lymphocyte cultured from patients infected with human immunodeficiency virus (HIV)].
    Cisterna R; Sarría L; Suñen E; Campelo C; Martínez J; Fernández de Aránguiz A; Gorriño T; Malavé C
    Enferm Infecc Microbiol Clin; 1990 May; 8(5):282-5. PubMed ID: 2090229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.
    Lau JY; Bird GL; Naoumov NV; Williams R
    Dig Dis Sci; 1993 May; 38(5):888-95. PubMed ID: 7683263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection and significance of anti-pre S2 in patients with hepatitis B and HBsAg carriers].
    Ding Z
    Zhonghua Yi Xue Za Zhi; 1990 Nov; 70(11):611-4, 42. PubMed ID: 1963350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
    Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta infection in asymptomatic carriers of hepatitis B surface antigen: low prevalence of delta activity and effective suppression of hepatitis B virus replication.
    Chen PJ; Chen DS; Chen CR; Chen YY; Chen HM; Lai MY; Sung JL
    Hepatology; 1988; 8(5):1121-4. PubMed ID: 3417233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.